| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.937675 |
| 003 | CaOODSP |
| 005 | 20240823151040 |
| 006 | m o d f |
| 007 | cr mn||||||||| |
| 008 | 240502e202403 onc o f000 0 eng d |
| 020 | |a9780660717258 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aHP5-244/2024E-PDF |
| 245 | 00|aSeasonal influenza vaccination coverage survey, 2023-2024 : |bfinal report / |csubmitted to the Public Health Agency of Canada ; prepared by Leger. |
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cMarch 2024. |
| 264 | 4|c©2024 |
| 300 | |a1 online resource (45 pages) + |eexecutive summary (6 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Enquête sur la couverture vaccinale contre la grippe saisonnière, 2023-2024 : rapport final. |
| 500 | |a"Contract Number: CW2340342." |
| 500 | |a"Registration number: POR 099-23." |
| 650 | 0|aInfluenza vaccines|zCanada|xPublic opinion. |
| 650 | 0|aCOVID-19 vaccines|zCanada|xPublic opinion. |
| 650 | 0|aPublic opinion|zCanada. |
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
| 710 | 2 |aLéger Marketing, |econsultant. |
| 775 | 08|tEnquête sur la couverture vaccinale contre la grippe saisonnière, 2023-2024 : |w(CaOODSP)9.937676 |
| 795 | |tSeasonal influenza vaccination coverage survey, 2022-2023 : |w(CaOODSP)9.920731 |
| 856 | 40|qPDF|s493 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-244-2024-eng.pdf|zFinal report |
| 856 | 40|qPDF|s237 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-244-2024-1-eng.pdf|zExecutive summary |
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2024/099-23-e/POR099-23-report.html|zFinal report |
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2024/099-23-e/summary/POR099-23-summary.html|zExecutive summary |